Skip to main content

Table 2 Comparison between baseline and end-of-treatment laboratory investigations among enrolled patients with CHA and HCV

From: Microelimination of hepatitis C in patients with chronic hemolytic anemias: a single-center experience

Lab Mean ± SD Significance
Baseline End-of-treatment
Hb (g/dl) 8.51±1.28 8.4±1.2 p<0.501
Ferritin (ng/ml) 1807.63±1480.36 1762.63±1918.7 p<0.339
T.Bil (mg/dl) 2.62±1.11 2.49±1.48 p<0.542
ALT (IU/l) 54.48±22.9 41.41±24.02 p<0.009
Albumin (g/dl) 4.09±0.48 4.3±0.5 p<0.182
INR 1.17±0.09 1.2±0.14 p<0.341
FIB-4 0.78±0.7 0.61±0.5 p<0.175
APRI 0.44±0.27 0.32±0.22 p<0.046